Xention Limited Strengthens Team with New Director of Business Development
While at GSK, Dr Graham was responsible for business development and licensing within the neurosciences therapeutic area. He led the evaluation of numerous licensing and acquisition opportunities, including completion of over twenty-five due diligences and the successful completion of numerous, substantial deals. Prior to this, he held senior roles in a number of other departments within GSK including Head of Disease Strategy in the Neurology & GI Centre of Excellence for Drug Discovery (CEDD) and Assistant Director in the Anti-Infective Therapeutic Unit. He holds a PhD in Pharmacology from the University of Dundee.
Most read news
Topics
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.